01
Low NADAC$10.62
→
Avg plan cost$11.15
Part D spend $2.03B
1× spread, current vs floor
Drug class profile · refreshed daily from federal data
Long-Acting Muscarinic Antagonist (Bronchodilator)
1 molecule in this class, $2.03B combined CY2024 Part D spend across 3.0M claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily
Class summary at a glance.
Every drug in the Long-Acting Muscarinic Antagonist (Bronchodilator) class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 1tracked in Part D
- CY24 Part D spend
- $2.03Bcombined across class
- Total Rx claims
- 3.0M928K unique beneficiaries
- Generic mfrs (active)
- 1across all molecules